Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807534-77-5
1146195-72-3
2055014-69-0
1454662-54-4
2086689-04-3
2100306-72-5
1835759-87-9 | M-Peg3-onhboc | AA019E15 | MFCD29052170
2055042-69-6 | Fmoc-peg3-ala-ala-asn(trt)-pab | AA019E52 | MFCD30182025
2100306-63-4 | N-(Boc-peg1)-n-bis(peg2-propargyl) | AA019E9B | MFCD30723238
2183440-29-9 | N-(t-butyl ester-PEG3)-N-bis(PEG3-amine) | AA019EE1 | MFCD31561124
1297537-37-1 | 2-Chloro-4-(1H-pyrazol-5-yl)benzonitrile | AA019EHV | MFCD28365702
225122-33-8 | tert-Butyl (1-((cyanomethyl)carbamoyl)cyclohexyl)carbamate | AA019EKZ | MFCD24392169
959466-51-4 | 2,4-bis(phenylmethoxy)-5-propan-2-ylbenzaldehyde | AA019ENS | MFCD24849960
107208-70-8 | 2-bromo-2-chloro-1,1-biphenyl | AA019EQZ | MFCD00466291
58826-39-4 | 6-Chloro-7-methyl-[1,2,4]triazolo[4,3-b]pyridazine | AA019ETZ | MFCD04037382
1554658-43-3 | 4-Chloro-3-fluoro-2-methoxybenzaldehyde | AA019EXF | MFCD24686301
53130-43-1
39753-69-0
775351-90-1
306736-05-0
449782-73-4
898413-02-0